Table 2.
Significant covariates | ΔMOFV | p-value |
---|---|---|
Univariate analysis | ||
Effect of GLU on V/F | −4.674 | <0.05 |
Effect of eGFR on CL/F | −6.658 | <0.01 |
Effect of LAMF on ka1 | −6.587 | <0.01 |
Multivariate analysis | ||
Effect of eGFR on CL/F | 52.145 | <0.001 |
MFOV, minimum objective function; GLU, glucose; V/F, apparent volume of distribution; eGFR, estimated glomerular filtration rate; CL/F, apparent total clearance of metformin; LAMF, left arm fat; ka1, absorption rate constant at the first absorption site